Company Profile
Samjin Pharmaceuticals manufactures and sells medicine. It offers medicine in oral, drop, and injecting forms. The company provides over-the-counter medicines, such as Gevorin, an anti-infalammatory pain killer.
Its portfolio also includes Trestan, an appetite stimulant, Flaris, an anti-thrombotic agent, and Nutilin, a brain function improvement agent medicine for treatment of chronic diseases. It also develops SA001, which is in Phase II clinical trial for the treatment for dry eye syndrome and Sjogren syndrome.
Its portfolio also includes SJP1804 medicine that is Phase I clinical trial to treat macular degeneration, SJP1604, which is in Phase I clinical trial for cancer, SJP1901 and SJP1902 for cancer treatment, SJP 1801 to treat Alzheimer's and Parkinson's disease, SJP006, an anti-viral product, and SJP003 for treatment of diabetes. Additionally, it's preclinical product is SJP1602 for the treatment of cancer. Founded in 1968, Samjin Pharmaceuticals is headquartered in Seoul, South Korea.